July 2011 marked the 10th anniversary of the formation of the
McGowan Institute for Regenerative Medicine
. The starting organizational entities were the McGowan Center for Artificial Organ Development and about 75 faculty members who conducted independent research programs in their respective departments.
As the title suggests, the original McGowan Center's focus was on the development of
• artificial organs and supporting technologies, such as drag reducing agents,
• drugs that reduce damage from angioplasty, and
• scaffolding used to support cells for tissue-engineered applications, such as a myocardial patch.
Through faculty-led strategic planning, the vision, mission, and programmatic focus evolved for a multidisciplinary team of what is now ~230 McGowan Institute for Regenerative Medicine affiliated faculty who are advancing the science and the clinical implementation of a multitude of regenerative medicine-based therapies.
An overview of the formation and growth of the McGowan Institute for Regenerative Medicine and a synopsis of the achievements of the McGowan Institute affiliated faculty is